Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2000
06/08/2000WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000009750A9 Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression
06/08/2000WO2000008212A9 Gel microdrops in genetic analysis
06/08/2000WO1999064835A8 Screening method for dehydrogenase oligomerisation modulators
06/08/2000WO1999064572A3 Poly(adp-ribose) polymerase gene
06/08/2000DE19958198A1 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs)
06/08/2000DE19856152A1 New heterocyclylalkene substituted quinolinium and pyridinium derivatives useful for labelling of biomolecules, particles and pharmaceuticals
06/08/2000DE19855865A1 Instantaneous determination of chemical oxygen demand of effluent or usable water, by measurement of uptake of highly active oxygen e.g. injected ozone
06/08/2000DE19854946A1 Klonieren und Kopieren an Oberflächen Cloning and copying at surfaces
06/08/2000DE19852105A1 Sample collection of oil from contaminated water surfaces, using an oleophilic web material attached to a float
06/08/2000CA2566516A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2354187A1 Calcitonin for the modulation of sperm function
06/08/2000CA2353795A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
06/08/2000CA2353793A1 Length determination of nucleic acid repeat sequences by discontinuous primer extension
06/08/2000CA2353643A1 Methods for producing selected interstrand cross-links in chromosomal nucleic acids and applications thereof
06/08/2000CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics
06/08/2000CA2353562A1 Method and system for detecting oligonucleotides in a sample
06/08/2000CA2353557A1 Inhibitors of multidrug transporters
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353387A1 Device and method to control steel pickling processes
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353103A1 Method for separating nucleic acids into populations
06/08/2000CA2353080A1 Control of flowering
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
06/08/2000CA2352568A1 Methods for introducing heterologous cells into fish
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352532A1 Compositions and methods for increasing bone mineralization
06/08/2000CA2352134A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2351398A1 Analyte test instrument having improved calibration and communication processes
06/08/2000CA2350069A1 Methods to reduce variance in treatment studies using genotyping
06/08/2000CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/08/2000CA2291458A1 Process for the specific detection of glycosylated proteins
06/07/2000EP1006364A1 Immunoassay for detection of mutant P53 polypeptide in biological fluids
06/07/2000EP1006363A2 Biochip and method for producing the same
06/07/2000EP1006362A1 Method and apparatus for the separation of components from a biological material
06/07/2000EP1006361A2 Leukocyte classification reagent
06/07/2000EP1006360A2 Device and method for separating components of a fluid sample
06/07/2000EP1006359A2 Device and method for separating components of a liquid sample
06/07/2000EP1006358A1 Detection of contaminants in food
06/07/2000EP1006353A2 Oxygen sensor monitoring
06/07/2000EP1006352A2 NOx-decomposing electrode and NOx concentration-measuring apparatus
06/07/2000EP1006200A2 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
06/07/2000EP1006199A1 Applications with and methods for producing selected interstrand crosslinks in nucleic acid
06/07/2000EP1006198A1 A non-invasive method for the functional assessment of infants and children with an inherited metabolic disorder
06/07/2000EP1006194A2 C-erbB-2 external domain: GP75
06/07/2000EP1006186A1 Human genes
06/07/2000EP1006185A1 Tissue-specific splice variant of recombination-repair gene rad51b associated with t(12;14)-uterine leiomyomas
06/07/2000EP1006184A1 IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
06/07/2000EP1006183A1 Recombinant soluble Fc receptors
06/07/2000EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs
06/07/2000EP1006178A2 An immortal cell line derived from grouper Epinephelus coioides and its applications
06/07/2000EP1005910A2 Centrifuge tube with cylindrically symmetric separation element, liner and cap
06/07/2000EP1005909A2 Centrifuge tube with round separation element, liner and cap
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005655A2 Method of drug selection
06/07/2000EP1005654A2 Novel method of detecting amyloid-like fibrils or protein aggregates
06/07/2000EP1005653A1 Method of producing a subtraction library
06/07/2000EP1005652A1 Antigens embedded in thermoplastic
06/07/2000EP1005651A1 Methods of identifying biological agent compositions
06/07/2000EP1005650A1 Bis-biotin compounds for specific binding assays
06/07/2000EP1005649A1 Non-enzymatic methods of generating chemiluminescence from acridan alkenes
06/07/2000EP1005648A1 Method for measuring without combustion the heat value of fuel gas
06/07/2000EP1005647A1 Sensor unit, especially for measuring air quality
06/07/2000EP1005646A1 Housing for a flammable gas detector
06/07/2000EP1005644A1 Biosensor device and method
06/07/2000EP1005641A1 Method/apparatus for cell differentiation measuring cell size, membrane integrity, intracellular complexity
06/07/2000EP1005633A1 A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method
06/07/2000EP1005632A2 Method and apparatus for real time gas analysis
06/07/2000EP1005572A1 Solid support with attached molecules
06/07/2000EP1005569A2 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
06/07/2000EP1005566A1 Regeneration of biosensors
06/07/2000EP1005549A2 Prostate tumor polynucleotide and antigen compositions
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005544A1 70 human secreted proteins
06/07/2000EP1005540A1 Ikk-beta proteins, nucleic acids and methods
06/07/2000EP1005539A1 IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS
06/07/2000EP1005533A1 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response
06/07/2000EP1005486A1 Inducible regulatory system and use thereof
06/07/2000EP1005483A1 Methods and compositions for rapid furification of proteasomes and methods of use of components thereof
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005365A1 Abundant extracellular products and methods for their production and use
06/07/2000EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection
06/07/2000EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
06/07/2000EP1005360A1 Antioxidant protein 2, gene and methods of use therefor
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005330A1 Methods and compositions for targeting compounds to muscle
06/07/2000EP1005305A1 Thin absorbent article
06/07/2000EP0812331A4 Mhc-antigen complexes for detecting and purifying antigen-specific t cells
06/07/2000EP0806965A4 Cd44 expression in smooth muscle cells
06/07/2000EP0636171B1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse malignant cells
06/07/2000CN1255971A Sampling device for chlorinated organic compounds
06/07/2000CN1255948A Prediction of coronary artery disease
06/07/2000CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors
06/07/2000CN1255637A Antihemagglutinin and blood examining method
1 ... 3108 3109 3110 3111 3112 3113 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 ... 3937